CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 4 Long-term Follow-up Study to Define the Safety Profile of Radium-223 Dichloride

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02312960
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:42.083098+00:00
Published At: 2025-01-30T00:00:00+00:00
Record Updated At: 2025-03-25
Results Posted At: 2025-01-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neoplasm Metastasis / Bone and Bones"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-25"
protocolSection.identificationModule.nctId: "NCT02312960"
protocolSection.identificationModule.officialTitle: "A Phase 4 Long-term Follow-up Study to Define the Safety Profile of Radium-223 Dichloride"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-01-30"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.